TRILASYM Oral solution (2019)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
Name of the medicinal product
Trilasym 50 mg/5 ml Oral Solution.
Qualitative and quantitative composition
Each 5 ml of Oral Solution contains 50 mg of amantadine hydrochloride. Excipient(s) with known effect: Each 5 ml also contains: 3250 mg of sorbitol (E420) 10 mg of sodium benzoate (E211) 6.5 mg raspberry ...
Pharmaceutical form
Oral Solution. Clear, colourless, raspberry-flavoured liquid.
Therapeutic indications
Prophylaxis and treatment of signs and symptoms of infection caused by influenza A virus Trilasym is indicated in patients suffering from clinical influenza in which complications might be expected to ...
Posology and method of administration
Influenza A Treatment When treating influenza, the treatment should start as early as possible and to continue for 4 to 5 days. When amantadine is started within 48 hours of symptoms appearing, the duration ...
Contraindications
Known hypersensitivity to amantadine or any of the excipients listed in section 6.1 Individuals subject to convulsions A history of gastric ulceration Severe renal disease Pregnancy and breast-feeding ...
Special warnings and precautions for use
Trilasym should be used with caution in: patients with confusional or hallucinatory states or underlying psychiatric disorders patients with liver or kidney disorders patients suffering from, or who have ...
Interaction with other medicinal products and other forms of interaction
Anticholinergic agents or levodopa Concurrent administration may increase confusion, hallucinations, nightmares, gastro-intestinal disturbances, or other atropine-like side effects (see section 4.9 Overdose ...
Fertility, pregnancy and lactation
Pregnancy Amantadine-related complications during pregnancy have been reported. Trilasym is contraindicated during pregnancy and in women trying to become pregnant. Breastfeeding Trilasym is excreted in ...
Effects on ability to drive and use machines
Patients should be warned of the potential hazards of driving or operating machinery if they experience side effects such as dizziness or blurred vision.
Undesirable effects
Amantadines undesirable effects are often mild and transient, usually appearing within the first 2 to 4 days of treatment and promptly disappearing 24 to 48 hours after discontinuation. A direct relationship ...
Overdose
Overdose with amantadine can lead to a fatal outcome. Signs and symptoms Neuromuscular: disturbances and symptoms of acute psychosis are prominent. Central nervous system: hyperreflexia, motor restlessness, ...
Pharmacodynamic properties
Pharmacotherapeutic group: Antiparkinsonian agent and anti-influenzal virostatic ATC code: N04BB01 Mechanism of action Influenza Trilasym specifically inhibits the replication of influenza A viruses at ...
Pharmacokinetic properties
Absorption Trilasym is absorbed slowly but almost completely. Peak plasma concentrations of approximately 250 ng/ml and 500 ng/ml are seen 3 to 4 hours after single oral administration of 100 mg and 200 ...
Preclinical safety data
Reproductive toxicity studies were performed in rats and rabbits. In rat, oral doses of 50 and 100 mg/kg proved to be teratogenic. This is 33-fold the recommended dose of 100 mg for influenza. The maximum ...
List of excipients
Sodium benzoate (E211) Sorbitol (E420) Raspberry flavour containing ethanol, propylene glycol (E1520) and benzyl alcohol Citric acid monohydrate Purified Water
Incompatibilities
None known.
Shelf life
Shelf life: 24 months. After first opening the bottle: 1 month.
Special precautions for storage
Store below 25°C. Store in the original bottle, in order to protect from light.
Nature and contents of container
Type III amber glass bottle with a tamper evident polypropylene child-resistant screw cap with a polyethylene inner liner containing 150ml of solution with a polypropylene dosing cup. Pack size: 150 ml. ...
Special precautions for disposal and other handling
The box containing this medicine contains a plastic measuring cup. The cup is marked in ml (millilitres) to help measuring out the correct amount. This medicine should be taken using the measuring cup ...
Marketing authorization holder
Fontus Health Ltd, 60 Lichfield Street, Walsall, WS4 2BX, United Kingdom
Marketing authorization number(s)
PL 42924/0020
Date of first authorization / renewal of the authorization
03/05/2019
Date of revision of the text
16/09/2019
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:
